VISMO SAYS:   CHECK OUT THE VISMODEGIB PORTAL!       The vismodegib portal is up and running! Check it out to learn more about advanced BCC and to see what the vismodegib team has been up to. Access the vismodegib portal                   Learn what Genentech is telling physicians in the "About Advanced BCC" section.   Watch spotlight team interviews to get insight about vismodegib.   Listen to vismodegib fans from around the world in the Pronunciation App.         FOR INTERNAL USE ONLY. NOT FOR PROMOTION OR DISTRIBUTION. Note: For background information only. Not for promotional use. This e-mail is an update on our late-stage molecule that is currently being researched in clinical trials and is not yet approved by the Food and Drug Administration (FDA). Because of FDA policies, we will not promote this molecule prior to FDA approval. This communication is intended for internal information only and is not for promotions or distribution to external audiences, including Healthcare Providers. Please do not forward this email.